Category Archives: Yehiel Tal

Collplant reports Q3 FY2018 results, reinforces commitment to 3D bioprinter materials

Regenerative medicine company and 3D bioprinter material developer Collplant (NASDAQ:CLGN) , has reported its financial results for the third quarter of 2018. Headline revenue for the three months ended September 30, 2018 was $224,000, a 209% increase on the same period in 2017, which was $73,000. The increase is reflective of the growing commercialization of the company’s proprietary […]

3D Printing News Sliced Ford, PyroGenesis, Collplant, MIT, Royal DSM

Today, in our Sliced roundup of all the latest 3D printing industry news, we take a look inside some 3D printed houses, uncover progress on the coveted field of organ 3D bioprinting, and collect the latest materials and hardware releases to keep you, the most well informed readers in the industry, up to date. News […]

$5 million funding regenerates CollPlant’s 3D printed organ development plans

Israeli regenerative medical materials developer CollPlant is to move ahead with its long-term “rhCollagen” project of developing 3D printed transplantable organs, thanks to a $5 million investment from US venture capital firm Alpha Capital in September.  This news comes after CollPlant established an entire division dedicated to 3D printing in May of this year. CollPlant also filed […]

3D printing business roundup: Canada Makes, HP, Collplant, CRP Group

Building toward some of the biggest events in the 3D printing industry calendar, additive manufacturing companies are announcing their latest business deals including new investments, partnerships and international distribution. In this article, we review recent activity from Canada Makes, EOS, CRP Group, HP, Nano Dimension, Thales Group, A*STAR and CollPlant. Canada Makes partners with 3D design […]